Efficacy and safety of ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor, in chronic obstructive pulmonary disease: A systematic review and meta-analysis

Efficacy and safety of ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor, in chronic obstructive pulmonary disease: A systematic review and meta-analysis

<h3>Background </h3><p dir="ltr">We evaluated the efficacy and safety of Ensifentrine in COPD via a systematic review and meta-analysis of randomized controlled trials (RCTs). </p><h3>Methods </h3><p dir="ltr">We performed a detailed lite...

Full description

Saved in:
Bibliographic Details
Main Author: Eeshal Fatima (18255772) (author)
Other Authors: Obaid Ur Rehman (6555554) (author), Zain Ali Nadeem (20487218) (author), Umar Akram (20151411) (author), Riyan Imtiaz Karamat (19927596) (author), Muhammad Omar Larik (20365932) (author), Maurish Fatima (19231394) (author), Joshua Chitwood (20487221) (author), Arslan Ahmad (7400501) (author), Sarah Esposito (20487224) (author), Abdulqadir J. Nashwan (11659453) (author)
Published: 2024
Subjects:
Biomedical and clinical sciences
Clinical sciences
Pharmacology and pharmaceutical sciences
Ensifentrine
COPD
Dual PDE3 and PDE4 inhibitors
Phosphodiesterase inhibitors
Meta analysis
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items